Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions - Takeaways - MDSpire

Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions

  • By

  • Ivo G. Schoots

  • Monique J. Roobol

  • March 13, 2019

  • 0 min

Share

  • 1

    Transrectal ultrasound-guided systematic biopsy has increased the risk of antibiotic-resistant infections and detection of low-grade prostate cancer.

  • 2

    Multivariate risk prediction models are now recommended to assess the risk of clinically significant prostate cancer and reduce unnecessary biopsies.

  • 3

    Prostate multi-parametric MRI is increasingly used to improve diagnostic accuracy and may help defer biopsies in men without suspected significant disease.

  • 4

    New MRI risk prediction models have been developed, incorporating mpMRI scores, to enhance the decision-making process for prostate cancer biopsies.

  • 5

    Studies show that MRI-based risk prediction models significantly improve the accuracy of identifying clinically significant prostate cancer.

Original Source(s)

Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions

  • by Ivo G. Schoots, Monique J. Roobol

  • March 13, 2019

Related Content

PHI density prospectively improves prostate cancer detection

Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies

Early experience with targeted and combination biopsies in prostate cancer work-up in Denmark from 2012 to 2016